JPRN-UMIN000010050CompletedPhase 1
Phase Ia/Ib multicenter investigator initiated trial of Mogamulizumab for advanced or recurrent cancer. - Phase Ia/Ib multicenter investigator initiated trial of Mogamulizumab for advanced or recurrent cancer.
Aichi Medical University School of Medicine, Department of Tumor Immunology0 sites58 target enrollmentStarted: February 15, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 58
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) Patients with HIV antibody positive. (2) Patients with HCV antibody positive. (3) Patients with autoimmune disease. (4) Patients with HBs antigen or HBV-DNA positive. (5) History of serious anaphylaxis induced by antibody preparation. (6) Patients with double cancer. (7) Within 4 weeks after treatment with anticancer agent, immune suppressant, immune enhancer, cytokine therapy, radiotherapy or surgery for the primary disease. (8) Pregnant or breast-feeding females and females who have a possibility of pregnancy. (9) Patients with active infection. (10) Patients with psychosis or dementia. (11) Patients who need continuous systemic administration of adrenocorticosteroid. (12) Patients who have received hematopoietic stem cell transplantation. (13) Patients who have presence or suspicion of CNS involvement. (14) Patients who are administered the other investigational product within 4 weeks of the entry. (15) Patients treated with immunotherapy for cancer (e.g. cancer vaccine therapy) within 12 weeks of the entry. (16) Any other inadequacy for this study.
Investigators
Similar Trials
Completed
Phase 3
Phase III Investigator-Initiated Trial to Investigate Safety and Efficacy of Edoxaban in Patients with Chronic Thromboembolic Pulmonary HypertensioChronic Thromboembolic Pulmonary HypertensionCTEPH, DOAC, warfarinJPRN-jRCT2071200098Abe Kohtaro74
Completed
Phase 1
Phase I/IIa investigator-initiated multicenter single-arm open-label study of the safety and efficacy of intravenous HUCV002-01 in patients with chronic heart failureChronic heart failureJPRN-UMIN000035004Kyushu University Hospital5
Active, not recruiting
Phase 1
Mifepristone 50mg as a weekly ContraceptivePrevention of unwanted pregnancyEUCTR2020-000866-41-Outside-EU/EEAWomen on Web International Foundation
Completed
Not Applicable
TiFFANY TRsolid malignanciesJPRN-jRCT1080224720ational Cancer Center Hospital East26
Recruiting
Phase 2
Phase IIb investigator-initiated multicenter study of the efficacy and safety of intravenous HUCV002-01 in patients with chronic heart failure (continuous study)heart failure, cardiomyopathyD006333chronic heart failureJPRN-jRCT2073220002Tsutsui Hiroyuki15